Biosynthesis & Natural Products

Ribosomally Synthesized and Post-Translationally Modified Peptides (RiPPs)

Summary

RiPPs represent a diverse superfamily of natural products that are biosynthesized through ribosomal translation of a precursor peptide followed by extensive enzymatic modifications. Unlike NRPS products, RiPPs are genetically encoded, allowing for rapid diversification through mutation.

Key Points

  • 1RiPPs are genetically encoded natural products made by ribosomal translation then enzymatic modification
  • 2Precursor peptides contain a leader (for enzyme recognition) and core (becomes product) region
  • 3Major classes include lanthipeptides, thiopeptides, lasso peptides, and cyanobactins
  • 4Post-translational modifications create heterocycles, macrocycles, and unusual crosslinks
  • 5Genetic tractability enables rapid diversification through mutation and genome mining

# Ribosomally Synthesized and Post-Translationally Modified Peptides (RiPPs)

Ribosomally synthesized and post-translationally modified peptides (RiPPs) constitute a rapidly expanding class of natural products characterized by their ribosomal origin and subsequent enzymatic tailoring. This biosynthetic logic combines the efficiency of ribosomal translation with the chemical diversity achievable through post-translational modifications.

Precursor Peptide Architecture

Three-Domain Organization

RiPP precursor peptides typically contain:

- Leader peptide: N-terminal region recognized by modification enzymes

- Core peptide: The region that becomes the mature natural product

- Follower peptide: Optional C-terminal recognition element (in some classes)

Recognition and Processing

  • Leader peptides contain conserved motifs for enzyme binding
  • Modification enzymes bind the leader while acting on the core
  • Proteolytic removal of the leader releases the mature product
  • Major RiPP Classes

    Lanthipeptides (Lantibiotics)

  • Contain lanthionine and methyllanthionine crosslinks
  • - Nisin: The prototypical lantibiotic used in food preservation

  • Formed by dehydration of Ser/Thr followed by Michael addition of Cys
  • Thiopeptides

  • Highly modified with a central pyridine/dehydropiperidine macrocycle
  • - Thiostrepton: Ribosome-targeting antibiotic

  • Contain multiple thiazole and dehydroamino acid modifications
  • Lasso Peptides

  • Unique [1]rotaxane topology with threaded tail through macrolactam ring
  • Exceptional proteolytic and thermal stability
  • - Microcin J25: Antibacterial RNA polymerase inhibitor

    Cyanobactins

  • Cyclic peptides from cyanobacteria
  • Contain heterocycles (thiazoles, oxazoles) and prenyl groups
  • - Patellamide A: Cytotoxic compound from ascidian symbionts

    Sactipeptides

  • Contain sulfur-to-alpha-carbon (sactionine) crosslinks
  • Radical SAM enzymes catalyze C-S bond formation
  • - Subtilosin A: Antimicrobial from Bacillus subtilis

    Biosynthetic Logic

    Modification Enzyme Classes

    | Enzyme Type | Modification | Example |

    |-------------|--------------|---------|

    | Dehydratases | Ser/Thr → Dha/Dhb | LanB/LanM |

    | Cyclases | Thioether formation | LanC/LanM |

    | Heterocyclases | Azole formation | YcaO |

    | Radical SAM | C-H functionalization | Various |

    | Prenyltransferases | Isoprenoid addition | PagF |

    The RiPP Precursor Recognition Element (RRE)

  • Conserved structural domain in modification enzymes
  • Binds specifically to leader peptide sequences
  • Positions the core peptide for efficient modification
  • Evolutionary and Biotechnological Significance

    Genetic Tractability

  • Simple point mutations alter the core peptide sequence
  • Leader peptides can be swapped between systems
  • Enables combinatorial biosynthesis approaches
  • Genome Mining

  • Bioinformatic identification of RiPP gene clusters
  • Precursor peptide identification by conserved leader sequences
  • Discovery of novel classes continues at rapid pace
  • Engineering Applications

    - Phage display-like selection of RiPP variants

  • Integration with synthetic biology platforms
  • Drug development: macrocyclic peptidomimetics